Yale University at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Yale University takes part in 6 sessions at ESMO 2026 in Madrid. Its program spans biomarker testing in gastroesophageal cancer, vaccines for kidney cancer and telisotuzumab adizutecan in later-line colorectal cancer. Other sessions cover a cryocompression device for chemotherapy-induced peripheral neuropathy and supportive and palliative care.

Organization

ESMO 2026 Attendance

Yale University

New Haven, CT

University & institute

Private Ivy League university in New Haven, Connecticut, with a school of medicine and an NCI-designated comprehensive cancer centre.

Talk

Sat Oct 24
08:50–09:10

Challenges in biomaker testing

Optimising personalised care for gastroesophageal cancer

Gastrointestinal cancers

Abstract

Sat Oct 24
15:20–15:25

791RO - Long-term follow-up of Telisotuzumab Adizutecan (ABBV-400, Temab-A) in combination with bevacizumab (Bev) vs standard of care (SOC) in patients (pts) with 3L+ colorectal cancer (CRC): Updated results of a phase 1 study

Rapid oral: Gastrointestinal tumours, lower digestive

Gastrointestinal cancers

Talk

Sun Oct 25
11:15–11:35

Emerging new systemic therapies for RCC

Genitourinary cancers

Abstract

Mon Oct 26
10:15–10:20

3837RO - ABBV-706: A First-in-Class SEZ6-Targeted Topoisomerase 1 Inhibitor (Top1i)- Antibody-Drug Conjugate (ADC) With Robust Antitumour Activity in Relapsed/Refractory Small Cell Lung Cancer (R/R SCLC)

Rapid oral: Non-metastatic NSCLC and other thoracic malignancies

Lung & thoracic cancers

Satellite

Mon Oct 26
13:25–13:35

Review of the development of a new cryocompression medical device for the management of CIPN in chemotherapy settings

Paxman - Addressing Chemotherapy-Induced Peripheral Neuropathy with Cryocompression: Protecting Function and Quality of Life for Patients

Nursing & supportive care

Talk

Tue Oct 27
11:00–11:20

Supportive and palliative care

Scientific Congress Highlights 2

Instantly find 20 buyers from Yale University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction